Image

PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS

PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Extracorporeal life support (ECLS) is used as a last resort intervention in patients with severe cardiac, circulatory and/or respiratory failure with high (>80%) expected mortality. Despite considerable improvements in patient selection and outcomes, mortality and morbidity after ECLS remain high. An improved selection and management of patients who are supported with ECLS is therefore unquestionably needed from a perspective of optimal patient care and the socio-economic impact of this costly intervention.

Description

This observational multicenter study was designed to serve the following objectives:

  1. Develop a (dynamic) prediction tool for survival and quality of life outcomes 1 year after ECLS support for the situation at baseline and 7 days after ECLS initiation
  2. Study the association between application of left ventricular unloading and ECLS support duration and weanability
  3. Description of the incidence of VA ECLS weaning failure and identification of predictors for VA ECLS weaning failure

Under this umbrella research protocol, the data collected by this observational multicenter study can also be reused for potential novel substudies with the objective to improve the quality of care and the efficiency of current treatment strategies involving ECLS.

Eligibility

Inclusion Criteria:

  • Having received (VA and/or VV) ECLS
  • All ECLS indications (refractory cardiac, circulatory and/or respiratory failure)
  • Surgical and medical patients

Exclusion Criteria:

  • < 18 years of age
  • ECLS confined to cardiac surgery in the operating room (OR) or in the catheterization laboratory
  • Objection against use of clinical data (opt-out principle)

Study details
    Extracorporeal Membrane Oxygenation
    Extracorporeal Membrane Oxygenation Complication

NCT05444764

UMC Utrecht

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.